Skip to content
DraconiticResearch
Search Sources API
203,234 studies31 sourcesUpdated 12 min ago
Peer-reviewedCC BYAnnals of clinical and translational neurology

Glucagon‐Like Peptide‐1 Receptor Agonists in Multiple Sclerosis: A Topical Narrative Review

  1. 1Northwestern University

Related

  1. Glucagon-like peptide-1 receptor agonists beyond weight loss: A paradigm shift in cardiovascular prevention
    Alaa Solaiman Algazzar
    Saudi Journal of Internal MedicinePeer-reviewedCC BY-NC-NDFull textEndocrinology & metabolismDOAJ
  2. Divergent ocular safety profiles of glucagon-like peptide-1 receptor agonists: a pharmacological heterogeneity framework
    Huili Li, Shengke Peng, Daoxi Lei
    Frontiers in medicinePeer-reviewedCC BYFull textGeneral medicineEurope PMC
  3. Glucagon-Like Peptide 1 Receptor Agonists, Mortality, and Cardiovascular Outcomes in Serious Mental Illness
    Roger S. McIntyre, Yanli Zhang-James, Angela T. H. Kwan
    JAMA PsychiatryPeer-reviewedLicence not statedFull text1 citedEndocrinology & metabolismPMC
  4. Modern Obesity Treatment: Efficacy, Safety, and Future Directions of GLP-1 (Glucagon-Like Peptide-1) and GIP (Glucose-Dependent Insulinotropic Polypeptide) Receptor Agonists
    Dorota Bartkowiak, Barlomiej Jakubczyk, Adam Lasota +7
    CureusPeer-reviewedCC BYFull textGeneral medicineEurope PMC
  5. Comparative Short-Term Risk of Severe Gastrointestinal Events Associated with Opioid Type Among Patients Receiving Glucagon-Like Peptide-1 Receptor Agonists
    Sungho Bea, Elisabetta Patorno, Sushama Kattinakere Sreedhara +5
    Diabetes carePeer-reviewedLicence not statedFull textEpidemiology & public healthPMC
BibTeX
@article{chang2026glucagonlike,
  title = {{Glucagon‐Like Peptide‐1 Receptor Agonists in Multiple Sclerosis: A Topical Narrative Review}},
  author = {Audrey Y. Chang and Farrah J. Mateen},
  journal = {Annals of clinical and translational neurology},
  year = {2026},
  month = oct,
  url = {https://europepmc.org/article/PMC/PMC13655708},
  note = {CC BY},
}
RIS
TY  - JOUR
TI  - Glucagon‐Like Peptide‐1 Receptor Agonists in Multiple Sclerosis: A Topical Narrative Review
AU  - Audrey Y. Chang
AU  - Farrah J. Mateen
PY  - 2026
DA  - 2026/10/12
JO  - Annals of clinical and translational neurology
UR  - https://europepmc.org/article/PMC/PMC13655708
SN  - 2328-9503
ER  -